Salarius Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing potential new cancer medicines for patients in need of new treatment options. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader. Salarius Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing potential new cancer medicines for patients in need of new treatment options. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.3288 | -18.8965517241 | 1.74 | 1.7455 | 1.38 | 75387 | 1.59567259 | CS |
4 | -0.0188 | -1.31468531469 | 1.43 | 2.35 | 1.26 | 941323 | 1.68456294 | CS |
12 | -0.8088 | -36.4324324324 | 2.22 | 2.35 | 1.26 | 380533 | 1.69942823 | CS |
26 | -2.5248 | -64.1463414634 | 3.936 | 7.2 | 1.26 | 1379845 | 2.63036618 | CS |
52 | -5.0088 | -78.0186915888 | 6.42 | 7.44 | 1.26 | 732047 | 2.72463944 | CS |
156 | -158.5888 | -99.118 | 160 | 172 | 1.26 | 481570 | 28.57394392 | CS |
260 | -952.5888 | -99.8520754717 | 954 | 1098 | 1.26 | 682151 | 178.98434956 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales